About Adcendo

Adcendo is a clinical-stage biotech company dedicated to developing transformative first-in-class ADC therapies for cancers with high unmet medical need.

We are headquartered in Copenhagen, Denmark, where our team of highly specialized experts pioneer the development of groundbreaking new treatments though a combination of deep understanding of the biology of novel targets, suitable optimized ADC linker/payload technologies and targeted solid tumor indications.

We collaborate with international biotech and life science investors, technology & manufacturing partners and scientific and clinical experts.

Our vision is to develop transformative first-in-class ADCs for solid tumor patients with a high unmet medical need.